And That Happened: Monday’s scores and highlights

58 Comments

Four games? Really? What, people were supposed to watch hockey or something?

[Shut up, Calcaterra, hockey pays the bills around here — Ed.]

Um, congratulations, Chicago Blackhawks!

Padres 4, Phillies 3: Philly took a three-run lead into the bottom of the ninth with Cliff Lee still pitching a shutout when he began the inning.  Then Kyle Blanks happened. Lee allowed the first two runners to reach and was relieved by Jonathan Papelbon, still up 3-0. Blanks promptly drove in two with a single. Blanks advanced to second when Papelbon hit the next batter with a pitch and Blanks took third on a double play. Then, oops, Carlos Ruiz allowed a passed ball which scored Blanks and onto extra innings we went. In the tenth the Padres loaded the bases with two walks and another hit-by-pitch after which Blanks won it with an RBI single. What a dispiriting way to lose a game.

Indians 5, Orioles 2: Michael Brantley drove in four as the Indians won for the ninth time in 12 games. That’s four straight losses for the O’s.

Dodgers 3, Giants 1: Yasiel Puig homers again — his seventh — and broke a tie with an RBI single in the eighth. After the game A.J. Ellis said of Puig, “he’s hitting everything and hitting it hard. I’m just really happy he’s on our side.” I think they said that about Dr. Manhattan too. The Dodgers have won three in a row, which is their longest winning streak of the season.

Rays 4, Blue Jays 1: Jeremy Hellickson shut out the Jays for seven innings, allowing only one hit. James Loney, Wil Myers and Sam Fuld went back-to-back-to-back in the second. The Jays’ winning streak ends at 11.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.